Parkinson's disease involves autophagy and abnormal distribution of cathepsin L

Neuroscience Letters

Volumn 489, Issue 1, 2011, Pages 62-67

  Li, Lingyun ^a,b   Wang, Xiaoxia ^c   Fei, Xifeng ^a   Xia, Liping ^a   Qin, Zhenghong ^a   Liang, Zhongqin ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

6 Hydroxydopamine; Autophagy; Cathepsin L; Neurodegeneration; Parkinson's disease

Indexed keywords

3 METHYLADENINE; CATHEPSIN L; OXIDOPAMINE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; AUTOPSY; CELL VACUOLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; LYSOSOME; MALE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA;

ANIMALS; AUTOPHAGY; CATHEPSIN L; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEURONS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 78650824020     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.11.068     Document Type: Article

References (23)

1. Andringa G., Lam K.Y., Chegary M., Wang X., Chase T.N., Bennett M.C. Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease. FASEB J. 2004, 18:932-934.
2. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 1997, 12:25-31.
3. Biswas G., Guha M., Avadhani N.G. Mitochondria-to-nucleus stress signaling in mammalian cells: nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis. Gene 2005, 354:132-139.
4. Biswas G., Tang W., Sondheimer N., Guha M., Bansal S., Avadhani N.G. A distinctive physiological role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling. J. Biol. Chem. 2008, 283:12586-12594.
5. Boland B., Campbell V. Abeta-mediated activation of the apoptotic cascade in cultured cortical neurones: a role for cathepsin-L. Neurobiol. Aging 2004, 25:83-91.
6. Chu C.T., Plowey E.D., Dagda R.K., Hickey R.W., Cherra S.J., Clark R.S. Autophagy in neurite injury and neurodegeneration: in vitro and in vivo models. Methods Enzymol. 2009, 453:217-249.
7. Chung K.K., Dawson V.L., Dawson T.M. New insights into Parkinson's disease. J. Neurol. 2003, 250(Suppl. 3):15-24.
8. Dagda R.K., Zhu J., Kulich S.M., Chu C.T. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease. Autophagy 2008, 4:770-782.
9. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., Cuny G.D., Mitchison T.J., Moskowitz M.A., Yuan J. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 2005, 1:112-119.
10. Dickson D.W. Linking selective vulnerability to cell death mechanisms in Parkinson's disease. Am. J. Pathol. 2007, 170:16-19.
11. Fei X.F., Qin Z.H., Xiang B., Li L.Y., Han F., Fukunaga K., Liang Z.Q. Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. Brain Res. 2009, 1264:85-97.
12. Felbor U., Kessler B., Mothes W., Goebel H.H., Ploegh H.L., Bronson R.T., Olsen B.R. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:7883-7888.
13. Kaasik A., Rikk T., Piirsoo A., Zharkovsky T., Zharkovsky A. Up-regulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium. Eur. J. Neurosci. 2005, 22:1023-1031.
14. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Yoshimori T., Ohsumi Y., Tokuhisa T., Mizushima N. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
15. Lankelma J.M., Voorend D.M., Barwari T., Koetsveld J., Van der Spek A.H., De Porto A.P., Van Rooijen G., Van Noorden C.J. Cathepsin L. target in cancer treatment?. Life Sci. 2010, 86:225-233.
16. Larsen K.E., Fon E.A., Hastings T.G., Edwards R.H., Sulser D. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J. Neurosci. 2002, 22:8951-8960.
17. Lehmensiek V., Tan E.M., Liebau S., Lenk T., Zettlmeisl H., Schwarz J., Storch A. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. Neurochem. Int. 2006, 48:329-340.
18. Li L.Y., Zhao X.L., Fei X.F., Gu Z.L., Qin Z.H., Liang Z.Q. Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra. Acta. Pharmacol. Sin. 2008, 29:539-547.
19. Liang Z.Q., Li Y.L., Zhao X.L., Han R., Wang X.X., Wang Y., Chase T.N., Bennett M.C., Qin Z.H. NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53. Brain Res. 2007, 1145:190-203.
20. Pan T., Kondo S., Le W., Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008, 131:1969-1978.
21. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2004, Elsevier Academic press. 5th ed.
22. Prigione A., Piazza F., Brighina L., Begni B., Galbussera A., Difrancesco J.C., Andreoni S., Piolti R., Ferrarese C. Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease. Neurosci. Lett. 2010, 477:6-10.
23. Sevenich L., Pennacchio L.A., Peters C., Reinheckel T. Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice. Biol. Chem. 2006, 387:885-891.